KAT2A and cancer: Gcn5 has been extensively studied for its role in epigenetic regulation and its involvement in the pathogenesis of various diseases, including cancers, diabetes, obesity, metabolic disease and syndrome, dyslipidemia, neurological disorders, infectious diseases, immune disorders, heart failure, muscle diseases, and aging [10,11].